Oxacillin resistance of staphylococcus aureus isolated from the university hospital of Botucatu medical school in Brazil

Chemotherapy

Volumn 56, Issue 2, 2010, Pages 112-119

  Martins, André ^a   Pereira, Valéria Cataneli ^a   Cunha, Maria De Lourdes R S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cefoxitin; E test; MecA; MRSA; Oxacillin; Staphylococcus aureus

Indexed keywords

BETA LACTAMASE; CEFOXITIN; COTRIMOXAZOLE; ERYTHROMYCIN; NETILMICIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; VANCOMYCIN;

AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; DISK DIFFUSION; ENZYME SYNTHESIS; EPSILOMETER TEST; GENE IDENTIFICATION; HUMAN; INTERMETHOD COMPARISON; MEDICAL SCHOOL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BRAZIL; CEFOXITIN; DRUG RESISTANCE, BACTERIAL; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; OXACILLIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77952248259     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313523     Document Type: Article

References (38)

1. Hiramatsu K, Chui L, Kuroda M, Ito T: The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001; 9: 486-493.
2. Tomasz A, Drugeon HB, Lencastre HM, Jabes D, McDougal L, Bille J: New mechanism for methicillin resistance in Staphylococcus aureus : clinical isolates that lack the PBP2a gene and contain normal penicillinbinding proteins with modified penicillinbinding capacity. Antimicrob Agents Chemother 1989; 33: 1869-1874.
3. Allerberger F, Lechner A, Wechsler-Fordos A, Gareis R, on behalf of ABS International: Optimization of antibiotic use in hospitals - antimicrobial Stewardship and the EU Project ABS International. Chemotherapy 2008; 54: 260-267.
4. Wey SB, Cardo DM, Halker E, Carratu FP, Saes AC: Distribution and analysis of 8,268 nosocomial infections at the Hospital Sao Paulo: 1985 to 1989 . Rev Hosp S Paulo Esc Paul Med 1990; 1: 169-174.
5. Keseru JS, Gal Z, Barabas G, Benko I, Szabo I: Investigation of beta-lactamases in clinical isolates of Staphylococcus aureus for further explanation of borderline methicillin resistance. Chemotherapy 2005; 51: 300-304.
6. CLSI - Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15. Wayne, NCCLS, 2005.
7. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing, 16th Informational Supplement M100-S16. Wayne, National Committee on Clinical Laboratory Standards, 2006.
8. Perez LRR, Antunes LLS, Barth AL, D'Azevedo PA: Variations of agar screen tests for detection of methicillin resistance in staphylococci: focus on cefoxitin. Eur J Clin Microbiol Infect Dis 2007; 26: 267-270.
9. Tveten Y, Jenkins A, Digranes A, Melby KK, Allum AG, Kristiansen BE: Comparison of PCR detection of mecA with agar dilution and Etest for oxacillin susceptibility testing in clinical isolates of coagulase negative staphylococci. Clin Microbiol Infect 2004; 10: 462-465.
10. Koneman EW, Allen SD, Janda NM, Schreckenberger PC, Winn JR: Color Atlas and Textbook of Diagnostic Microbiology, ed 5. Philadelphia, Lippincott, 1997, p 1395.
11. Baker JS: Comparison of various methods for differentiation of staphylococci and micrococci. J Clin Microbiol 1984; 19: 875-879.
12. Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG: Species-specific and ubiquitous- DNA-based assays for rapid identification of Staphylococcus aureus. J Clin Microbiol 1998; 6: 618-623.
13. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement M100-S18. Wayne, National Committee on Clinical Laboratory Standards, 2008.
14. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing. NCCLS Approved Standard M100-S9. Wayne, National Committee for Clinical Laboratory Standards, 1999.
15. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S: Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991; 29: 2240-2244.
16. Ghoshal U, Prasad KN, Singh M, Tiwari DP, Ayyagari A: A comparative evaluation of phenotypic and molecular methods for the detection of oxacillin resistance in coagulase- negative staphylococci. J Infect Chemother 2004; 10: 86-89.
17. Sox HC Jr: Probability theory in the use of diagnostic tests. An introduction to critical study of the literature. Ann Intern Med 1986; 104: 60-66.
18. Fletcher RH, Fletcher SW, Wagner EH: Diagnostico, in: Epidemiologia Clinica. Porto Alegre, Artes Medicas, 1991, pp 68-107.
19. Archer GL, Niemeyer DM: Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol 1994; 2: 343-347.
20. Swenson JM: News tests for detection of oxacillin- resistant Staphylococcus aureus. Clin Microbiol Newslett 2002; 24: 159-162.
21. Felten A, Grandry B, Lagrange PH, Casin I: Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 2002; 40: 2766-2771.
22. Boutiba-Ben Boubaker I, Ben Abbes R, Ben Abdallah H, Mamlouk K, Mahjoubi F, Kammoun A, Hammami A, Ben Redjeb S: Evaluation of a cefoxitin disk diffusion test for the routine detection of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2004; 10: 762-765.
23. Zhu LX, Zhang ZW, Wang C, Yang HW, Zhang Q, Cheng J: Evaluation of the CLSI cefoxitin 30-μg disk-diffusion method for detecting methicillin resistance in staphylococci. Clin Microbiol Infect 2006; 12: 1039-1042.
24. Broekema NM, Van TT, Monson TA, Marshall SA, Warshauer DM: Comparison of cefoxitin and oxacillin disk diffusion methods for detection of mecA -mediated resistance in Staphylococcus aureus in a largescale study. J Clin Microbiol 2009; 47: 217-219.
25. Cauwelier B, Gordts B, Descheemaecker P, Van Landuyt H: Evaluation of a disk diffusion method with cefoxitin (30μ g) for detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2004; 23: 389-392.
26. Fernandes CJ, Fernandes LA, Collingnon P: Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2005; 55: 506-510.
27. Livermore DM: Antibiotic resistance in staphylococci. Int J Antimicrob Agents 2000; 16:S3-S10.
28. Centers for Disease Control and Prevention (CDC): Vancomycin-resistant Staphylococcus aureus - Pennsylvania. MMWR Morb Mortal Wkly Rep 2002; 51: 902.
29. Souza Antunes AL, Secchi C, Reiter KC, Rodrigues Perez LR, Peixoto de Freitas AL, Alves d'Azevedo P: Evaluation of oxacillin and cefoxitin disks for detection of resistance in coagulase negative staphylococci. Mem Inst Oswaldo Cruz 2007; 102: 719-723.
30. Frebourg NB, Nouet D, Lemee L, Martin E, Lemeland JF: Comparison of ATB staph, rapid ATB staph, Vitek, and E-test methods for detection of oxacillin heteroresistance in staphylococci possessing mecA . J Clin Microbiol 1998; 36: 52-57.
31. Velasco D, del Mar Tomas M, Cartelle M, Beceiro A, Perez A, Molina F, Moure R, Villanueva R, Bou G: Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus . J Antimicrob Chemother 2005; 55: 379-382.
32. Chi CY, Ho MW, Ho CM, Lin PC, Wang JH, Fung CP: Molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus bacteremia in a teaching hospital. J Microbiol Immunol Infect 2007; 40: 310-316.
33. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K: Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin- resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001; 45: 1323-1336.
34. Martins A, Cunha MRS: Methicillin resistance in Staphylococcus aureus and coagulase- negative staphylococci: epidemiological and molecular aspects. Microbiol Immunol 2007; 51: 787-795.
35. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM: Prevalence of methicillin resistant staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh . Indian J Med Microbiol 2003; 21: 49-51.
36. Cavalcanti SM, Franca ER, Cabral C, Vilela MA, Montenegro F, Menezes D, Medeiros AC: Prevalence of Staphylococcus aureus introduced into intensive care units of a University Hospital. Braz J Infect Dis 2005; 9: 56-63.
37. Massanari RM, Pfaller MA, Wakefield DS, Hammons GT, McNutt LA, Woolson RF, Helms CM: Implications of acquired oxacillin resistance in the management and control of Staphylococcus aureus infections. J Infect Dis 1988; 158: 702-709.
38. Thauvin-Eliopoulos C, Rice LB, Eliopoulos GM, Moellering RC Jr: Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by betalactamase- hyperproducing Staphylococcus aureus. Antimicrob Agents Chemother 1990; 34: 728-732.